经肘正中静脉行临时心脏起搏器安置术的临床疗效分析  

Clinical Efficacy of Temporary Artificial Pacemaker Placement via Median Cubital Vein

作　　者：邹文博 李立 张进 王会莲 Zou Wenbo;Li Li;Zhang Jin;Wang Huilian(Department of Cardiovascular,Yidu Hospital of Traditional Chinese Medicine,Yidu 443000,China)

机构地区：[1]宜都市中医医院心血管科,湖北宜都443000

出　　处：《巴楚医学》2024年第3期81-85,共5页Bachu Medical Journal

基　　金：湖北省卫生健康委科研项目(No:WJ2021F062)。

摘　　要：目的:探讨经肘正中静脉行临时心脏起搏器安置术的有效性及安全性。方法:本研究纳入2020年8月—2024年4月期间在宜都市中医医院行临时心脏起搏安置术的49例患者,根据静脉入路随机分为对照组(n=25)和观察组(n=24)。对照组采用传统路径(即经股静脉置入),观察组采用经肘正中静脉路径。比较两组患者临床疗效。结果:与对照组相比,观察组患者穿刺置管用时[(1.67±2.24) min vs (4.87±1.28) min]及放射量[(13.07±3.92) mGy vs (15.63±4.65) mGy]均显著降低,舒适状况量表(GCQ)评分[(66.04±3.12)分vs (52.23±4.56)分]明显升高,两组患者术后并发症发生率无明显差异(均P>`0.05)。结论:经肘正中静脉路径行临时心脏起搏器置入术安全有效,值得临床推广应用。Objective:To explore the effectiveness and safety of temporary cardiac pacemaker implantation via the median cubital vein.Methods:This study included 49 patients who underwent temporary cardiac pacemaker implantation at Yidu Hospital of Traditional Chinese Medicine from August 2020 to April 2024.The patients were randomly divided into a control group(n=25)and an observation group(n=24)according to the venous access route.The control group received the traditional route(implantation via the femoral vein),while the observation group received the median cubital vein route.The clinical efficacy of the two groups was compared.Results:Compared with the control group,the time for puncture and catheterization[(1.67±2.24)min vs(4.87±1.28)min],radiation dose[(13.07±3.92)mGy vs(15.63±4.65)mGy]in the observation group were significantly lower,the general comfort questionnaire score(66.04±3.12)vs(52.23±4.56)was significantly higher,and there was no significant difference in the incidence of postoperative complications between the two groups of patients(P>0.05).Conclusion:Temporary cardiac pacemaker implantation via the median cubital vein is safe and effective,which is worthy of clinical promotion and application.

关 键 词：临时心脏起搏器 置入术 肘正中静脉 股静脉 

分 类 号：R654.2[医药卫生—外科学]